Founder of a Major Russian Pharmaceutical Company Listed as SDN in the UK

09 February 2023

On 8 February 2023 Alexey Repik, the founder of R-Pharm – Russian pharmaceutical company, producing, among other things, drugs for COVID-19 (e.g. coronavir (favipiravir) and artlegia (olokizumab)) was listed in the UK Sanctions List.

Reasoning behind this decision is that he holds the position of the Chairman of the Board of R-Pharm, which receives financing from the Russian Direct Investment Fund – a Government of Russia-affiliated entity. Moreover, Alexey Repik is also designated as a person associated with Vladimir Putin, the Russian President.

New Responsibility for Selling Drugs Without Prescription

06 February 2023

On January 17, 2023, a bill was submitted to the State Duma for consideration. This bill establishes higher responsibility for the sale of medicines subject to quantitative accounting without a prescription.

The relevant bill has been introduced in order to combat drug addiction, which is nowadays widespread, including among minors, as stipulated in explanatory note to the bill.

US Has Authorized Provision of Accounting, Trust and Corporate Formation, and Management Consulting Services to Russian Persons in Spheres of Agricultural Commodities and Medicine

30 January 2023

The new General license No 6C published by OFAC on January 1, 2023, establishes exceptions from US sanctions related to the spheres of agricultural commodities, medicine, medical devices, replacement parts and components for medical devices, or software updates for medical devices.

Certain Russian Companies Will Be Able to Make Decisions Without Calculating Votes of Minor Shareholders Associated with Unfriendly Foreign States

23 January 2023

On 17 January 2023, the Decree of the President of the Russian Federation "On the temporary procedure for decision-making by the bodies of some business companies" was signed and published. It introduces several changes in decision-making for a number of large Russian companies.

The Russian Constitutional Court Has Allowed Reimbursement of Legal Costs Borne Before Rospatent as Court Costs

18 January 2023

The Russian Constitutional Court in its Ruling of 10 January 2023 No. 1-P  stated that art. 1248(2) of the Russian Civil Code along with art. 106 of the Russian Commercial Procedure Code are inconsistent with the Russian Constitution insofar they prevent a party in a court case on appealing the Rospatent decision to reimburse legal costs borne by this party in administrative dispute on annulling registration of intellectual property objects or means of individualization previously resolved by Rospatent.

From September 2023, Medical Examinations of Employees Can Be Carried Out Remotely

13 January 2023

From September 01, 2023, changes in the procedure for conducting medical examinations before, during and after a workday (shift) come into force. Namely, starting from September, employers will be granted the right to conduct such examinations remotely – using medical devices that provide automated remote transmission of information about the health status of employees and remote monitoring of their health status.